SecSonar.com

CeriBell, Inc. (CBLL)

CeriBell, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

CeriBell, Inc. (CBLL) is a Medical - Devices company based in US with a market capitalization of $703M. Revenue grew 36.1% year-over-year and free cash flow was negative at -$41.6M. This page tracks CBLL's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 281 employees · IPO Oct 11, 2024

Valuation

Valuation & price

$16.30 · as of May 17, 2026 · -30.4% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

4.53

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$23.43$17.18$10.92Jul 25Dec 25Jul 26Jul 7, 25$17.20Jul 9, 25$16.50Jul 11, 25$16.13Jul 15, 25$15.73Jul 17, 25$15.62Jul 21, 25$15.21Jul 23, 25$15.75Jul 25, 25$15.13Jul 29, 25$14.76Jul 31, 25$14.40Aug 4, 25$15.23Aug 6, 25$12.78Aug 11, 25$12.12Aug 13, 25$11.91Aug 15, 25$12.31Aug 19, 25$11.79Aug 21, 25$11.68Aug 25, 25$11.44Aug 27, 25$11.60Aug 29, 25$11.83Sep 3, 25$11.61Sep 5, 25$11.80Sep 9, 25$11.86Sep 11, 25$11.56Sep 16, 25$11.67Sep 18, 25$12.56Sep 22, 25$12.19Sep 24, 25$12.21Sep 26, 25$11.37Sep 30, 25$11.49Oct 2, 25$11.81Oct 6, 25$12.57Oct 8, 25$12.24Oct 10, 25$11.95Oct 14, 25$12.46Oct 16, 25$12.99Oct 21, 25$13.38Oct 23, 25$12.94Oct 27, 25$12.89Oct 29, 25$12.03Oct 31, 25$11.40Nov 4, 25$10.92Nov 6, 25$11.56Nov 10, 25$11.78Nov 12, 25$12.85Nov 14, 25$12.90Nov 18, 25$13.20Nov 20, 25$13.64Nov 25, 25$17.35Nov 28, 25$16.97Dec 2, 25$16.85Dec 4, 25$19.15Dec 8, 25$20.22Dec 10, 25$20.18Dec 12, 25$20.93Dec 16, 25$21.99Dec 18, 25$21.35Dec 22, 25$21.09Dec 24, 25$21.42Dec 29, 25$21.39Jan 2, 26$21.30Jan 6, 26$21.73Jan 8, 26$23.07Jan 12, 26$23.43Jan 14, 26$22.93Jan 16, 26$21.94Jan 21, 26$22.16Jan 23, 26$22.31Jan 27, 26$21.89Jan 29, 26$20.43Feb 2, 26$20.22Feb 4, 26$20.15Feb 9, 26$20.90Feb 11, 26$20.57Feb 13, 26$19.77Feb 18, 26$19.94Feb 20, 26$20.22Feb 24, 26$19.90Feb 26, 26$19.39Mar 2, 26$18.16Mar 4, 26$17.77Mar 6, 26$17.83Mar 10, 26$18.43Mar 12, 26$18.36Mar 17, 26$19.50Mar 19, 26$19.03Mar 23, 26$19.00Mar 25, 26$18.77Mar 27, 26$17.77Mar 31, 26$18.33Apr 2, 26$18.57Apr 7, 26$17.87Apr 9, 26$18.57Apr 13, 26$19.14Apr 15, 26$20.53Apr 17, 26$21.19Apr 22, 26$21.33Apr 24, 26$21.18Apr 28, 26$20.80Apr 30, 26$20.16May 4, 26$20.27May 6, 26$20.15May 8, 26$20.20May 12, 26$16.75May 14, 26$16.46May 18, 26$16.58May 20, 26$18.10May 22, 26$18.77May 28, 26$18.67Jun 1, 26$17.61Jun 3, 26$17.18Jun 5, 26$18.25Jun 9, 26$18.50Jun 11, 26$18.15Jun 15, 26$18.59Jun 17, 26$17.28Jun 22, 26$18.18Jun 24, 26$18.61Jun 26, 26$19.98Jul 2, 26$19.55
$10.9252-week range$23.43
Loading valuation history…

Fundamentals

Key fundamentals

$703M

Market cap

36.1%

Revenue growth (YoY)

87.9%

Gross margin

-$41.6M

Free cash flow (USD)

-$137M

Net debt

Net cash position

205.8%

Share dilution

1/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2022 → 2025

FY 2022$25.9MFY 2023$45.2MFY 2024$65.4MFY 2025$89.1M
$25.9M$89.1M

Free cash flow by year

2022 → 2025

FY 2022$-32.5MFY 2023$-30.1MFY 2024$-36.4MFY 2025$-41.6M
-$32.5M-$41.6M

Gross margin by year

2022 → 2025

FY 202282.9%FY 202384.4%FY 202486.7%FY 202587.9%
82.9%87.9%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

11

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 11, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $44K · 10b5-1 PlanBURKE WILLIAM W · Director · $43.8KJul 2, 2026Filing
  • Insider sellInsider Sell $101KTaylor Joseph Michael · Director · $101.3KJun 15, 2026Filing
  • Insider sellInsider Sell $715K · 10b5-1 PlanChao Xingjuan · Director, President and CEO · $714.9KJun 10, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 2, 2026Filing
  • Insider sellInsider Sell $109KChao Xingjuan · Director, President and CEO · $108.5KMay 26, 2026Filing
  • Insider sellInsider Sell $25KBlumberg Scott · Chief Financial Officer · $25KMay 26, 2026Filing
  • Insider sellInsider Sell $35KWoo Raymond · Chief Technology Officer · $35.4KMay 26, 2026Filing
  • Insider sellInsider Sell $34K · 10b5-1 PlanFoehr David · Senior VP, Finance and PAO · $34KMay 26, 2026Filing
  • Insider sellInsider Sell $25KManni Joseph S. · Chief Revenue Officer · $24.8KMay 26, 2026Filing
  • 8-K eventEarnings ReleaseMay 11, 2026Filing

Questions

Frequently asked questions

What is CeriBell, Inc.'s market cap?

CeriBell, Inc. (CBLL) has a market capitalization of $703M.

What is CBLL's P/E ratio?

A meaningful P/E ratio is not available for CBLL — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is CBLL's price-to-book (P/B) ratio?

CBLL trades at 4.53 times book value per share.

Are insiders buying CBLL stock?

SEC Form 4 filings show no open-market insider buys at CeriBell, Inc. in the last 90 days (11 sells).

Same arena

Related companies in Medical - Devices

SIBN

SI-BONE, Inc.

$631.8M

BWAY

BrainsWay Ltd.

$613.4M

CERS

Cerus Corporation

$612.8M

SSII

SS Innovations International, Inc.

$796.5M

NPCE

NeuroPace, Inc.

$590.8M

BVS

Bioventus Inc.

$580.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.